Assessment of the hospital anxiety and depression scale for cancer patients [Adaptación y validación de la Escala de Ansiedad y Depresión Hospitalaria en pacientes chilenos con cáncer]
MetadataShow full item record
Background: Depression and anxiety are common in patients with cancer. Aim: To adapt and validate the Hospital Anxiety and Depression Scale (HADS) for adult Chilean cancer patients, and to provide information about their prevalence of anxiety and depression. Material and Methods: Two hundred fifteen patients with cancer answered an adapted version of HADS for Chilean population. The language adjustment of the scale was carried out with the opinions of 10 expert linguists and with a pilot study on 17 cancer patients. The Depression and Anxiety subscales of the DASS-21 were also applied to verify the convergent validity of HADS: Results: The confirmatory factor analysis indicated that the data fits the model of two correlated factors (anxiety and depression), χ2 = 98.608; df = 76; p < 0.05; χ2/df = 1.23, RMSEA = 0.037; CFI = 0.99; TLI = .98. Reliability analysis showed an adequate internal consistency of both subscales (.76 for anxiety and .84 for depression) and the general scale (.87). Correlations between HADS and DASS-21 scores were significant for both anxiety (r =.514, p < 0.001) and depression (r = 0.600, p < 0.001). Prevalence rates were approximately 30% for depression (actual = 12%, possible = 22.8%) and approximately 20% for anxiety (actual = 7%, possible = 8.4%). Conclusions: We conclude that HADS is a reliable and valid instrument for screening clinically relevant anxiety and depression symptoms in Chilean cancer patients. © 2018, Sociedad Medica de Santiago. All Rights reserved.
Showing items related by title, author, creator and subject.
Design and psychometric evaluation of the quality of life in patients with anal fistula questionnaire (2020) Ferrer-Márquez M.; Espínola-Cortés N.; Reina-Duarte A.; Granero-Molina J.; Fernández-Sola C.; Hernández-Padilla J.M. (Lippincott Williams and Wilkins, 2017)
Normative values of EQ-5D-5L for diabetes patients from Spain [Datos normativos del EQ-5D-5L en pacientes diabéticos de España] (2020) Mateo D.C.; Gordillo M.A.G.; Olivares P.R.; Adsuar J.C. (Grupo Aula Medica S.A., 2015)
Effects of Behavioral Activation on the Quality of Life and Emotional State of Lung Cancer and Breast Cancer Patients During Chemotherapy Treatment (2020) Fernández-Rodríguez C.; Villoria-Fernández E.; Fernández-García P.; González-Fernández S.; Pérez-Álvarez M. (SAGE Publications Inc., 2019)